|
1
|
Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing.
|
J Cell Sci
|
2003
|
2.46
|
|
2
|
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.
|
Kidney Int
|
2012
|
2.38
|
|
3
|
Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases.
|
Mol Biol Cell
|
2003
|
2.11
|
|
4
|
Role of blood platelets in infection and inflammation.
|
J Interferon Cytokine Res
|
2002
|
2.01
|
|
5
|
Moderate altitude but not additional endurance training increases markers of oxidative stress in exhaled breath condensate.
|
Eur J Appl Physiol
|
2009
|
1.99
|
|
6
|
Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
|
Biochem J
|
2004
|
1.90
|
|
7
|
Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions.
|
J Interferon Cytokine Res
|
2005
|
1.65
|
|
8
|
Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway.
|
FEBS Lett
|
2002
|
1.60
|
|
9
|
Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element.
|
Biochem J
|
2005
|
1.45
|
|
10
|
Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact.
|
Blood
|
2005
|
1.41
|
|
11
|
Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA-2 and NF-kappaB.
|
FASEB J
|
2002
|
1.00
|
|
12
|
Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin.
|
FASEB J
|
2007
|
0.98
|
|
13
|
Thrombopoietin production in wild-type and interleukin-6 knockout mice with acute inflammation.
|
J Interferon Cytokine Res
|
2005
|
0.98
|
|
14
|
Lack of functional erythropoietin receptors of cancer cell lines.
|
Int J Cancer
|
2008
|
0.94
|
|
15
|
Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia.
|
Eur J Cancer
|
2006
|
0.91
|
|
16
|
Impact of erythropoietin on intensive care unit patients.
|
Transfus Med Hemother
|
2013
|
0.91
|
|
17
|
Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia.
|
J Clin Endocrinol Metab
|
2002
|
0.89
|
|
18
|
Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis.
|
Blood
|
2003
|
0.88
|
|
19
|
VEGF production by primary human renal proximal tubular cells: requirement of HIF-1, PI3-kinase and MAPKK-1 signaling.
|
Cell Physiol Biochem
|
2005
|
0.86
|
|
20
|
Thrombopoietin: the novel hepatic hormone.
|
News Physiol Sci
|
2002
|
0.86
|
|
21
|
Effects of chloroquine treatment on circulating erythropoietin and inflammatory cytokines in acute Plasmodium falciparum malaria.
|
Ann Hematol
|
2008
|
0.83
|
|
22
|
Efficacy of recombinant erythropoietins: is there unity of international units?
|
Nephrol Dial Transplant
|
2009
|
0.82
|
|
23
|
The Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT/HIF-1β) is influenced by hypoxia and hypoxia-mimetics.
|
Cell Physiol Biochem
|
2013
|
0.82
|
|
24
|
Progress in detecting cell-surface protein receptors: the erythropoietin receptor example.
|
Ann Hematol
|
2013
|
0.81
|
|
25
|
Stabilisation and knockdown of HIF--two distinct ways comparably important in radiotherapy.
|
Cell Physiol Biochem
|
2011
|
0.81
|
|
26
|
Nuclear-cytoplasmatic shuttling of proteins in control of cellular oxygen sensing.
|
J Mol Med (Berl)
|
2015
|
0.81
|
|
27
|
Erythropoietin and the skin: a role for epidermal oxygen sensing?
|
Bioessays
|
2009
|
0.80
|
|
28
|
Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF.
|
Strahlenther Onkol
|
2011
|
0.80
|
|
29
|
A multi-center study on the regenerative effects of erythropoietin in burn and scalding injuries: study protocol for a randomized controlled trial.
|
Trials
|
2013
|
0.79
|
|
30
|
Austrian Moderate Altitude Study (AMAS 2000) - fluid shifts, erythropoiesis, and angiogenesis in patients with metabolic syndrome at moderate altitude (congruent with 1700 m).
|
Eur J Appl Physiol
|
2002
|
0.79
|
|
31
|
Recombinant EPO production--points the nephrologist should know.
|
Nephrol Dial Transplant
|
2007
|
0.79
|
|
32
|
Problems in identifying functional erythropoietin receptors in cancer tissue.
|
J Clin Oncol
|
2007
|
0.79
|
|
33
|
Erythropoietin augments survival of glioma cells after radiation and temozolomide.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.78
|
|
34
|
'O', erythropoietin carbamoylation versus carbamylation.
|
Nephrol Dial Transplant
|
2008
|
0.77
|
|
35
|
Intolerability of cobalt salt as erythropoietic agent.
|
Drug Test Anal
|
2013
|
0.75
|
|
36
|
The elusive erythropoietin receptor.
|
Nephrol Dial Transplant
|
2012
|
0.75
|
|
37
|
Erythropoietin production: Molecular mechanisms of the antagonistic actions of cyclic adenosine monophosphate and interleukin-1.
|
FEBS Lett
|
2006
|
0.75
|
|
38
|
Thrombopoietin production in human hepatic cell cultures (HepG2) is resistant to IFN-alpha, IFN-beta, and IFN-gamma treatment.
|
J Interferon Cytokine Res
|
2002
|
0.75
|
|
39
|
Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome.
|
Arch Gynecol Obstet
|
2006
|
0.75
|
|
40
|
Does erythropoietin modulate human hair follicle melanocyte activities in situ?
|
Exp Dermatol
|
2009
|
0.75
|
|
41
|
Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia.
|
Onkologie
|
2005
|
0.75
|
|
42
|
Prolyl-4-Hydroxylase 2 Potentially Contributes to Hepatocellular Carcinoma-Associated Erythrocytosis by Maintaining Hepatocyte Nuclear Factor-4α Expression.
|
Cell Physiol Biochem
|
2015
|
0.75
|